Innovative Eyewear officer plans sale of 14,800 shares

Innovative Eyewear Inc (LUCY) is the issuer for a planned resale of its common stock under Rule 144 by Joaquin Abondano, identified as an officer.

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) is the issuer for a planned resale of its common stock under Rule 144 by Joaquin Abondano, identified as an officer. The notice covers a potential sale of up to 14,800 shares of common stock, originally received as an RSU grant, with Raymond James & Associates acting as broker.

The filing also reports that Abondano sold 5,020 shares of Innovative Eyewear common stock during the past three months for total proceeds of 3,288.00. The sales are to be made for cash on Nasdaq.

Key Figures

Shares to be sold under Rule 144: 14,800 shares Shares sold in past 3 months: 5,020 shares Proceeds from past 3 months’ sales: 3,288.00

3 metrics

Shares to be sold under Rule 144 14,800 shares Number of Innovative Eyewear common shares covered by the planned Rule 144 sale

Shares sold in past 3 months 5,020 shares Shares of Innovative Eyewear common stock sold by Joaquin Abondano during the past three months

Proceeds from past 3 months’ sales 3,288.00 Aggregate proceeds from 5,020 Innovative Eyewear common shares sold in the past three months

Key Terms

Rule 144, RSU Grant, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Grant financial

"Common | 08/19/2026 | RSU Grant | Issuer |"

attorney-in-fact regulatory

"as attorney-in-fact for Joaquin Abondano"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What type of transaction is Joaquin Abondano planning for Innovative Eyewear Inc (LUCY) shares?

Joaquin Abondano filed a notice to sell common stock of Innovative Eyewear Inc (LUCY) under Rule 144. The shares to be sold were received as an RSU grant from the issuer, and sales are planned to be executed for cash through Raymond James & Associates.

How many Innovative Eyewear (LUCY) shares are covered by this Rule 144 notice?

The Rule 144 notice covers a potential sale of up to 14,800 shares of Innovative Eyewear common stock. These shares are indicated as originating from an RSU grant from the issuer and may be sold for cash on Nasdaq.

What sales of LUCY stock has Joaquin Abondano made in the last three months?

Over the past three months, Joaquin Abondano sold 5,020 shares of Innovative Eyewear common stock, for aggregate proceeds of 3,288.00. These prior sales are reported in the same Rule 144 notice as required disclosure of recent transactions.

Who is the broker for Joaquin Abondano’s planned sales of Innovative Eyewear (LUCY) shares?

The planned sales of Innovative Eyewear (LUCY) common stock are to be executed through Raymond James & Associates, Inc., which is listed as the broker-dealer on the Rule 144 notice. Sales are expected to take place for cash on Nasdaq.

What is the origin of the Innovative Eyewear (LUCY) shares that may be sold by Joaquin Abondano?

The shares covered by this notice are identified as coming from an RSU grant from the issuer, Innovative Eyewear Inc. The Rule 144 filing specifies the security as common stock and lists the transaction type as an RSU grant from the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 12:48 PM EDT Accepted by SEC EDGAR 08/25/2026 - 12:47 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002008020
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovative Eyewear Inc
SEC File Number	001-41392
Address of Issuer	11900 BISCAYNE BLVD STE 630 MIAMI FLORIDA 33181
Phone	786-910-1898
Name of Person for Whose Account the Securities are To Be Sold	Abondano Joaquin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James and Associates 880 Carillon Parkway St. Petersburg FL 33716	631	167.55	8600000	08/19/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	RSU Grant	Issuer			14800	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joaquin Abondano 2 GROVE ISLE B308 Miami FL 33133	Common	08/19/2026	5020	3288.00

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Joaquin Abondano
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)